ARISg is web-based adverse event software solution that enables the collection, assessment and reporting of adverse event information to the global regulatory agencies. ARISg ensures compliance with international adverse drug event reporting obligations, providing expedited and periodic aggregate reporting while tracking KPIs and other critical metrics. ARISg is also core to an integrated pharmacovigilance and risk management strategy, enabling companies to monitor their products and provide early identification of product risks and safety trends.
Fully scalable, ARISg can be used by small operations in the early stages of clinical trials or large organizations with worldwide pharmacovigilance operations. The configurable workflow component allows ARISg users to set up the system to meet their business processes and SOPs for the global collection, coding, assessment and reporting of the data received. This advanced workflow streamlines case processing, automating the routing of cases to individuals as defined in the workflow based on the case details.
Compliant with the reporting requirements of major regulatory agencies, ARISg facilitates the entry and assessment of cases received, preparing the cases for regulatory reporting - either electronically or via traditional reporting methods.
To learn more about USDM and how we can assist with your compliance and business objectives, please contact:
Rebecca Meledy
888.231.0816 x161
775.213.5943 (fax)
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
"Simplify, Unify and Optimize your business & compliance needs with USDM"
